HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Supplement Marketers Continue Punching For Consumers’ Attention Through Celebrity Athletes

Executive Summary

Nutrabolt sponsors Top Rank boxing in Las Vegas three days before Super Bowl; iHerb collaborates with former heavyweight champion Mike Tyson; actor, athlete and ZOA Energy co-founder Dwayne Johnson touts line extension at GNC; and Roar Beverage collaborates with Peloton instructor Jess Sims.

You may also be interested in...



US Wellness Market People News: Herbalife, Bobbie Baby, Optimum Nutrition, Nutrabolt, More

“Gronk” motivates for Optimum Health; Osaka promotes paid paternal leave with Bobbie Baby; MidOcean changes CEOs at QualiTech; Nutrabolt expands revenue chief’s oversight; Gratziani climbs higher on Herbalife ladder; and Enzymedica adds Natural Group COO.

CopperGel's Heavyweight Promoter: Health And Wellness Industry News

Two energy beverages and an energy supplements roll out including Azoth's Total Energy, a supplement positioned to “counteract worker fatigue” without caffeine; former heavyweight boxing champ Mike Tyson enters supplement ring with CopperGel pain relief;and more news in brief.

Herbalife Executives' Investments Spark Uptick In Share Price After Results Send Stock Plummeting

Since closing at a 14-year low of $8.07 the day of the execs’ transactions, Herbalife shares trend steadily up from close of $8.26 on 20 February to $8.83 on 29 February. Some execs sell back some shares on 25 February at $8.67.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel